These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21697078)

  • 1. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.
    Tucci S; Flögel U; Sturm M; Borsch E; Spiekerkoetter U
    Am J Clin Nutr; 2011 Aug; 94(2):439-49. PubMed ID: 21697078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
    Tucci S; Primassin S; Spiekerkoetter U
    FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).
    Tucci S; Flögel U; Spiekerkoetter U
    Biochim Biophys Acta; 2015 Jul; 1852(7):1442-50. PubMed ID: 25887160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.
    Gélinas R; Thompson-Legault J; Bouchard B; Daneault C; Mansour A; Gillis MA; Charron G; Gavino V; Labarthe F; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H813-23. PubMed ID: 21685264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
    Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
    Tucci S; Primassin S; Ter Veld F; Spiekerkoetter U
    Mol Genet Metab; 2010 Sep; 101(1):40-7. PubMed ID: 20580297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
    Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice and the development of evidence.
    Wilcken B
    J Inherit Metab Dis; 2012 Jan; 35(1):3-4. PubMed ID: 21863278
    [No Abstract]   [Full Text] [Related]  

  • 16. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
    Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
    FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
    Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
    Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fatty acid biosynthesis and muscle fiber plasticity in very long-chain acyl-CoA dehydrogenase-deficient mice.
    Tucci S; Mingirulli N; Wehbe Z; Dumit VI; Kirschner J; Spiekerkoetter U
    FEBS Lett; 2018 Jan; 592(2):219-232. PubMed ID: 29237229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of mitochondrial bioenergetics and permeability transition induction caused by major long-chain fatty acids accumulating in VLCAD deficiency in skeletal muscle as potential pathomechanisms of myopathy.
    Cecatto C; Amaral AU; Roginski AC; Castilho RF; Wajner M
    Toxicol In Vitro; 2020 Feb; 62():104665. PubMed ID: 31629068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.